psalexa
P&S Market Research - A market research firm

Periodontitis Therapeutics Pipeline Analysis

Periodontitis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11263
Available Format:

Periodontitis is a type of disease that causes infections in gums and other tissues that support the teeth. The gums pull away from the teeth and form pockets. There are several risk factors associated with periodontitis such as smoking, metabolic disease, hormonal changes in women and girls, other illness such as HIV (human acquired immunodeficiency syndrome) and cancer, and certain medications that reduces the flow of saliva. Periodontitis can be symptomatized by bad breath, loose teeth, painful chewing, bleeding gums, swollen gums, and sensitive teeth. Geistlich Pharma AG is in the process of developing perioSept(r) as a lipopolysaccharide inhibitor for the treatment of periodontitis. Hebei Medical University is in the process of developing GMSCs and collagen scaffolds for the treatment of periodontitis. Some of the companies and universities having the pipeline of periodontitis include Hebei Medical University, Geistlich Pharma AG, and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry